Abstract
We sought to determine the effects of altering osmolarity and the reversibility of the detrimental immunologic effects of hypothermia on human monocyte HLA-DR surface expression and reactive oxygen species (ROS) formation. The effects of altering osmolarity on HLA-DR surface expression and ROS formation were assessed using lipopolysaccharide (LPS)-treated samples treated with either saline, glucose, or mannitol, incubated at 37°C for 2 hours. HLA-DR surface receptor expression and ROS formation were determined after incubation. The effects of the reversibility of hypothermia were measured by incubating LPS-treated samples at 34°C, 37°C, and 40°C for 1 hour. The samples were subsequently rewarmed at 40°C for 1 and 2 hours. The effects of rewarming on HLA-DR surface receptor expression and ROS formation were reassessed. In the osmolarity experiments, there was a 49% decrease in ROS formation in samples treated with mannitol as compared with saline and glucose. Alterations of osmolarity had no significant effect on HLA-DR surface expression. In the rewarming experiments, rewarming for either 1 or 2 hours abolished any significant differences in HLA-DR surface expression and ROS formation between samples preincubated at the different temperatures. The presumed inert mannitol was found to significantly decrease ROS formation, but had no effect on HLA-DR surface expression. In addition, the effects of hypothermia on HLA-DR surface expression or ROS formation may be better reversed within 2 hours than in 1 hour.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.